Bluue develops AI-powered medical devices including hand-held heart monitors that measure cardiac patterns and diagnose risk scores to determine the need for more invasive tests in cardiovascular patients. The hardware and software focus on heart and lung care as well as maternity care, utilizing frontier AI models and data collection devices. It employs a mathematical approach toward cardiovascular medicine, with patents such as US-11064950-B2 for hand-held monitoring. Healthcare professionals use these tools for cardiovascular treatment. Founded in 2013 by Dave Deriso, an AI researcher with an MS in Computational and Mathematical Engineering from Stanford, and researchers from Stanford, Oxford, and Berkeley. The company raised $270K across two seed rounds in 2016 and 2019. Headquarters are in Dover, DE.